Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market
Holding CRBU?
Track your performance easily

Caribou Biosciences (CRBU) Financial Statements

638 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently ―. The company's EPS TTM is $-1.388; its P/E ratio is -1.50; Caribou Biosciences is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 3.46M$ 2.43M$ 3.56M$ 23.66M$ 3.75M
Gross Profit$ 3.46M$ 2.43M$ 3.56M$ 23.66M$ 3.75M
EBIT$ -37.70M$ -46.00M$ -37.44M$ -10.00M$ -29.52M
EBITDA$ -35.30M$ -45.29M$ -36.70M-$ -31.01M
Net Income Common Stockholders$ -39.49M$ -41.23M$ -34.51M$ -10.00M$ -29.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 261.65M$ 293.99M$ 328.83M$ 338.49M$ 259.23M
Total Assets$ 372.94M$ 406.82M$ 432.21M$ 457.52M$ 349.65M
Total Debt$ 26.79M$ 27.16M$ 27.11M$ 27.45M$ 27.23M
Net Debt$ -234.86M$ -266.83M$ -301.72M$ -311.03M$ -232.00M
Total Liabilities$ 62.47M$ 63.54M$ 63.81M$ 59.25M$ 80.19M
Stockholders Equity$ 310.48M$ 343.29M$ 368.40M$ 398.27M$ 269.44M
Cash Flow-
Free Cash Flow$ -35.14M$ -38.65M$ -23.68M-$ -17.70M
Operating Cash Flow$ -32.90M$ -37.20M$ -21.40M$ -28.80M$ -15.14M
Investing Cash Flow$ 21.20M$ 22.96M$ -31.47M$ -68.48M$ 11.06M
Financing Cash Flow$ 132.00K$ 12.48M$ -43.00K$ 135.13M$ 17.57M
Currency in USD

Caribou Biosciences Earnings and Revenue History

Caribou Biosciences Debt to Assets

Caribou Biosciences Cash Flow

Caribou Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis